Global Anti-PD-1 MAb Market Size, Share, Trends and Forecast 2020-2026

Description

The global Anti-PD-1 MAb market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Anti-PD-1 MAb Scope and Segment
Anti-PD-1 MAb market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anti-PD-1 MAb market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
The following manufacturers are covered in this report:
Bristol Myers Squibb
Merck
Junshi Pharma
Innovent Biologics Inc
Hengrui Medicine
Beijing Beigene
...
Anti-PD-1 MAb Breakdown Data by Type
40mg
100mg
200mg
Others
Anti-PD-1 MAb Breakdown Data by Application
Melanoma Patients
Lung Cancer Patients
Lymphoma Patients
Other
Regional and Country-level Analysis
The Anti-PD-1 MAb market is analysed and market size information is provided by regions (countries).
The key regions covered in the Anti-PD-1 MAb market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Anti-PD-1 MAb Market Share Analysis

TABLE OF CONTENT

1 Study Coverage
1.1 Anti-PD-1 MAb Product Introduction
1.2 Market Segments
1.3 Key Anti-PD-1 MAb Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Anti-PD-1 MAb Market Size Growth Rate by Type
1.4.2 40mg
1.4.3 100mg
1.4.4 200mg
1.4.5 Others
1.5 Market by Application
1.5.1 Global Anti-PD-1 MAb Market Size Growth Rate by Application
1.5.2 Melanoma Patients
1.5.3 Lung Cancer Patients
1.5.4 Lymphoma Patients
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Anti-PD-1 MAb Market Size, Estimates and Forecasts
2.1.1 Global Anti-PD-1 MAb Revenue 2015-2026
2.1.2 Global Anti-PD-1 MAb Sales 2015-2026
2.2 Global Anti-PD-1 MAb, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Anti-PD-1 MAb Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Anti-PD-1 MAb Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Anti-PD-1 MAb Competitor Landscape by Players
3.1 Anti-PD-1 MAb Sales by Manufacturers
3.1.1 Anti-PD-1 MAb Sales by Manufacturers (2015-2020)
3.1.2 Anti-PD-1 MAb Sales Market Share by Manufacturers (2015-2020)
3.2 Anti-PD-1 MAb Revenue by Manufacturers
3.2.1 Anti-PD-1 MAb Revenue by Manufacturers (2015-2020)
3.2.2 Anti-PD-1 MAb Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anti-PD-1 MAb Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Anti-PD-1 MAb Revenue in 2019
3.2.5 Global Anti-PD-1 MAb Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Anti-PD-1 MAb Price by Manufacturers
3.4 Anti-PD-1 MAb Manufacturing Base Distribution, Product Types
3.4.1 Anti-PD-1 MAb Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-PD-1 MAb Product Type
3.4.3 Date of International Manufacturers Enter into Anti-PD-1 MAb Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Anti-PD-1 MAb Market Size by Type (2015-2020)
4.1.1 Global Anti-PD-1 MAb Sales by Type (2015-2020)
4.1.2 Global Anti-PD-1 MAb Revenue by Type (2015-2020)
4.1.3 Anti-PD-1 MAb Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Anti-PD-1 MAb Market Size Forecast by Type (2021-2026)
4.2.1 Global Anti-PD-1 MAb Sales Forecast by Type (2021-2026)
4.2.2 Global Anti-PD-1 MAb Revenue Forecast by Type (2021-2026)
4.2.3 Anti-PD-1 MAb Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Anti-PD-1 MAb Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Anti-PD-1 MAb Market Size by Application (2015-2020)
5.1.1 Global Anti-PD-1 MAb Sales by Application (2015-2020)
5.1.2 Global Anti-PD-1 MAb Revenue by Application (2015-2020)
5.1.3 Anti-PD-1 MAb Price by Application (2015-2020)
5.2 Anti-PD-1 MAb Market Size Forecast by Application (2021-2026)
5.2.1 Global Anti-PD-1 MAb Sales Forecast by Application (2021-2026)
5.2.2 Global Anti-PD-1 MAb Revenue Forecast by Application (2021-2026)
5.2.3 Global Anti-PD-1 MAb Price Forecast by Application (2021-2026)

6 North America
6.1 North America Anti-PD-1 MAb by Country
6.1.1 North America Anti-PD-1 MAb Sales by Country
6.1.2 North America Anti-PD-1 MAb Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Anti-PD-1 MAb Market Facts & Figures by Type
6.3 North America Anti-PD-1 MAb Market Facts & Figures by Application

7 Europe
7.1 Europe Anti-PD-1 MAb by Country
7.1.1 Europe Anti-PD-1 MAb Sales by Country
7.1.2 Europe Anti-PD-1 MAb Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti-PD-1 MAb Market Facts & Figures by Type
7.3 Europe Anti-PD-1 MAb Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Anti-PD-1 MAb by Region
8.1.1 Asia Pacific Anti-PD-1 MAb Sales by Region
8.1.2 Asia Pacific Anti-PD-1 MAb Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Anti-PD-1 MAb Market Facts & Figures by Type
8.3 Asia Pacific Anti-PD-1 MAb Market Facts & Figures by Application

9 Latin America
9.1 Latin America Anti-PD-1 MAb by Country
9.1.1 Latin America Anti-PD-1 MAb Sales by Country
9.1.2 Latin America Anti-PD-1 MAb Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Anti-PD-1 MAb Market Facts & Figures by Type
9.3 Central & South America Anti-PD-1 MAb Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Anti-PD-1 MAb by Country
10.1.1 Middle East and Africa Anti-PD-1 MAb Sales by Country
10.1.2 Middle East and Africa Anti-PD-1 MAb Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Anti-PD-1 MAb Market Facts & Figures by Type
10.3 Middle East and Africa Anti-PD-1 MAb Market Facts & Figures by Application

11 Company Profiles
11.1 Bristol Myers Squibb
11.1.1 Bristol Myers Squibb Corporation Information
11.1.2 Bristol Myers Squibb Description and Business Overview
11.1.3 Bristol Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bristol Myers Squibb Anti-PD-1 MAb Products Offered
11.1.5 Bristol Myers Squibb Related Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Description and Business Overview
11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Anti-PD-1 MAb Products Offered
11.2.5 Merck Related Developments
11.3 Junshi Pharma
11.3.1 Junshi Pharma Corporation Information
11.3.2 Junshi Pharma Description and Business Overview
11.3.3 Junshi Pharma Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Junshi Pharma Anti-PD-1 MAb Products Offered
11.3.5 Junshi Pharma Related Developments
11.4 Innovent Biologics Inc
11.4.1 Innovent Biologics Inc Corporation Information
11.4.2 Innovent Biologics Inc Description and Business Overview
11.4.3 Innovent Biologics Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Innovent Biologics Inc Anti-PD-1 MAb Products Offered
11.4.5 Innovent Biologics Inc Related Developments
11.5 Hengrui Medicine
11.5.1 Hengrui Medicine Corporation Information
11.5.2 Hengrui Medicine Description and Business Overview
11.5.3 Hengrui Medicine Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Hengrui Medicine Anti-PD-1 MAb Products Offered
11.5.5 Hengrui Medicine Related Developments
11.6 Beijing Beigene
11.6.1 Beijing Beigene Corporation Information
11.6.2 Beijing Beigene Description and Business Overview
11.6.3 Beijing Beigene Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Beijing Beigene Anti-PD-1 MAb Products Offered
11.6.5 Beijing Beigene Related Developments
11.1 Bristol Myers Squibb
11.1.1 Bristol Myers Squibb Corporation Information
11.1.2 Bristol Myers Squibb Description and Business Overview
11.1.3 Bristol Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bristol Myers Squibb Anti-PD-1 MAb Products Offered
11.1.5 Bristol Myers Squibb Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Anti-PD-1 MAb Market Estimates and Projections by Region
12.1.1 Global Anti-PD-1 MAb Sales Forecast by Regions 2021-2026
12.1.2 Global Anti-PD-1 MAb Revenue Forecast by Regions 2021-2026
12.2 North America Anti-PD-1 MAb Market Size Forecast (2021-2026)
12.2.1 North America: Anti-PD-1 MAb Sales Forecast (2021-2026)
12.2.2 North America: Anti-PD-1 MAb Revenue Forecast (2021-2026)
12.2.3 North America: Anti-PD-1 MAb Market Size Forecast by Country (2021-2026)
12.3 Europe Anti-PD-1 MAb Market Size Forecast (2021-2026)
12.3.1 Europe: Anti-PD-1 MAb Sales Forecast (2021-2026)
12.3.2 Europe: Anti-PD-1 MAb Revenue Forecast (2021-2026)
12.3.3 Europe: Anti-PD-1 MAb Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Anti-PD-1 MAb Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Anti-PD-1 MAb Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Anti-PD-1 MAb Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Anti-PD-1 MAb Market Size Forecast by Region (2021-2026)
12.5 Latin America Anti-PD-1 MAb Market Size Forecast (2021-2026)
12.5.1 Latin America: Anti-PD-1 MAb Sales Forecast (2021-2026)
12.5.2 Latin America: Anti-PD-1 MAb Revenue Forecast (2021-2026)
12.5.3 Latin America: Anti-PD-1 MAb Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Anti-PD-1 MAb Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Anti-PD-1 MAb Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Anti-PD-1 MAb Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Anti-PD-1 MAb Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Anti-PD-1 MAb Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anti-PD-1 MAb Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

Choose License Type

Checkout Inquiry Sample